Fair Value Measurements and Investments (Tables)
|
12 Months Ended |
Sep. 30, 2024 |
| Fair Value Disclosures [Abstract] |
|
| Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis |
Assets and Liabilities Measured at Fair Value on a Recurring Basis | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements as of September 30 Using Inputs Considered as | | Level 1 | | Level 2 | | 2024 | | 2023 | | 2024 | | 2023 | | (in millions) | | Assets | | | | | | | | | Cash equivalents and restricted cash equivalents: | | | | | | | | | Money market funds | $ | 10,403 | | | $ | 13,504 | | | $ | — | | | $ | — | | | | | | | | | | | U.S. Treasury securities | 7 | | | 301 | | | — | | | — | | | Investment securities: | | | | | | | | | Marketable equity securities | 301 | | | 339 | | | — | | | — | | | U.S. government-sponsored debt securities | — | | | — | | | 496 | | | 1,108 | | | U.S. Treasury securities | 4,948 | | | 4,316 | | | — | | | — | | | Other current and non-current assets: | | | | | | | | | Money market funds | 25 | | | 23 | | | — | | | — | | | Derivative instruments | — | | | — | | | 103 | | | 293 | | | Total | $ | 15,684 | | | $ | 18,483 | | | $ | 599 | | | $ | 1,401 | | | Liabilities | | | | | | | | | Accrued compensation and benefits: | | | | | | | | | Deferred compensation liability | $ | 238 | | | $ | 175 | | | $ | — | | | $ | — | | | Accrued and other liabilities: | | | | | | | | | Derivative instruments | — | | | — | | | 226 | | | 396 | | | Total | $ | 238 | | | $ | 175 | | | $ | 226 | | | $ | 396 | |
|
| Schedule of Amortized Cost, Unrealized Gains and Losses, and Fair Value of Debt Securities |
The amortized cost, unrealized gains and losses and fair value of debt securities were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | September 30, 2024 | | Amortized Cost | | Gross Unrealized | | Fair Value | | Gains | | Losses | | | (in millions) | | U.S. government-sponsored debt securities | $ | 492 | | | $ | 4 | | | $ | — | | | $ | 496 | | | U.S. Treasury securities | 4,920 | | | 40 | | | (5) | | | 4,955 | | | Total | $ | 5,412 | | | $ | 44 | | | $ | (5) | | | $ | 5,451 | |
| | | | | | | | | | | | | | | | | | | | | | | | | September 30, 2023 | | Amortized Cost | | Gross Unrealized | | Fair Value | | Gains | | Losses | | | (in millions) | | U.S. government-sponsored debt securities | $ | 1,109 | | | $ | 1 | | | $ | (2) | | | $ | 1,108 | | | U.S. Treasury securities | 4,697 | | | — | | | (80) | | | 4,617 | | | Total | $ | 5,806 | | | $ | 1 | | | $ | (82) | | | $ | 5,725 | |
Debt securities with unrealized losses for less than 12 months and 12 months or greater were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | September 30, 2024 | | Less Than 12 Months | | 12 Months or Greater | | Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses | | (in millions) | | U.S. government-sponsored debt securities | $ | — | | | $ | — | | | $ | 164 | | | $ | — | | | U.S. Treasury securities | — | | | — | | | 1,019 | | | (5) | | | Total | $ | — | | | $ | — | | | $ | 1,183 | | | $ | (5) | |
| | | | | | | | | | | | | | | | | | | | | | | | | September 30, 2023 | | Less Than 12 Months | | 12 Months or Greater | | Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses | | (in millions) | | U.S. government-sponsored debt securities | $ | 412 | | | $ | (2) | | | $ | 50 | | | $ | — | | | U.S. Treasury securities | 1,360 | | | (12) | | | 2,128 | | | (68) | | | Total | $ | 1,772 | | | $ | (14) | | | $ | 2,178 | | | $ | (68) | |
|
| Schedule of Debt Securities Classified by Contractual Maturity Date |
The stated maturities of debt securities were as follows: | | | | | | | | | | | September 30, 2024 | | | | (in millions) | | Due within one year | | $ | 2,968 | | Due after one year through five years | | 2,483 | | | Total | | $ | 5,451 | |
|
| Schedule of Non-Marketable Equity Securities |
The following table summarizes the Company’s non-marketable equity securities held as of period end that were accounted for using the fair value measurement alternative: | | | | | | | | | | | | | September 30, | | 2024 | | 2023 | | (in millions) | | Initial cost basis | $ | 711 | | | $ | 719 | | | Adjustments: | | | | | Upward adjustments | 910 | | | 899 | | | Downward adjustments, including impairment | (465) | | | (445) | | | Carrying amount | $ | 1,156 | | | $ | 1,173 | |
Unrealized gains and losses of the Company’s non-marketable equity securities held as of period end that were accounted for using the fair value measurement alternative were as follows: | | | | | | | | | | | | | | | | | | | For the Years Ended September 30, | | 2024 | | 2023 | | 2022 | | (in millions) | | Upward adjustments | $ | 10 | | | $ | 94 | | | $ | 231 | | Downward adjustments, including impairment | $ | (35) | | | $ | (99) | | | $ | (341) | |
|
| Schedule of Investment Income |
Investment income (expense) consisted of the following: | | | | | | | | | | | | | | | | | | | | For the Years Ended September 30, | | | 2024 | | 2023 | | 2022 | | | (in millions) | | Interest and dividend income on cash and investments | $ | 992 | | | $ | 745 | | | $ | 69 | | Gains (losses) on investments, net | (44) | | | (82) | | | (296) | | | Investment income (expense) | $ | 948 | | | $ | 663 | | | $ | (227) | |
|